Coronavirus LIVE: Biocon joins Adagio for licence to make antibody cocktail ...Middle East

The antibody treatment is based on ADG20, a novel monoclonal antibody, which targets the spike protein of SARS-CoV-2 and related coronaviruses

Hence then, the article about coronavirus live biocon joins adagio for licence to make antibody cocktail was published today ( Tuesday 27/07/2021 - 05:30 AM ) and is available on Business Standard ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Coronavirus LIVE: Biocon joins Adagio for licence to make antibody cocktail )

Also on site :

• New dime to celebrate America’s birthday takes on new meaning under Trump
• Xinhua Silk Road : la 34e Foire de l'Est de la Chine met à l'honneur la résistance et la vitalité du commerce extérieur
• Big Tech's Push to Make Electricity Cheaper